Influence
May 14, 2020

Regenstrief researcher leads in COVID-19 testing

An ongoing study led by Regenstrief research scientist and Indiana University’s Fairbanks School of Public Health at IUPUI (FSPH) faculty member Nir Menachemi, PhD, MPH, has released preliminary population-level data on COVID-19’s spread through Indiana.

In a recent press conference alongside Governor Eric J. Holcomb, Dr. Menachemi discussed the early findings of the study. Among these findings, the study team determined that 2.8% of Hoosiers have been infected with COVID-19. They also determined that in Indiana, COVID-19 showed a mortality rate of 0.58%, and that 10 out of 11 cases of COVID-19 were not being captured by current screening methods.

“As valuable is our data has been, it is the next wave, planned for early June, that will be even more valuable,” said Dr. Menachemi. “We plan to test another statewide random sample in a few weeks to determine how much the virus has further spread in Indiana. This information will be critical for decision makers.”

The groundbreaking study, a partnership between FSPH and the Indiana State Department of Health, has so far tested 4,600 randomly selected individuals. This sampling has helped the study team evaluate the overall spread and severity of the disease.

“Data is key in guiding our response in the fight against COVID-19, and our partnership with Fairbanks School of Public Health researchers will provide high quality information to help shape our decision making,” Governor Holcomb said. “I want to encourage Hoosiers who are selected to participate to step forward and help us gather the critical information for this groundbreaking scientific study.”

Related News

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

Regenstrief experts drive global dialogue on AI in healthcare at MedInfo 2025

Regenstrief experts drive global dialogue on AI in healthcare at MedInfo 2025

Regenstrief Institute research scientists and professional staff joined presenters from around the world at the MedInfo 2025 conference from